ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Insulin Glargine Injection shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2025-10-24 · last update 2025-10-24

Manufacturers: Eli Lilly and Co.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05)Eli Lilly and Co.To Be Discontinued
 —A business decision was made to discontinue manufacture of the drug.Posted 10/24/2025
Updated 10/24/2025
Discontinued 10/24/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)